Medullary Thyroid Cancer Clinical Trial
Study data from Johns Hopkins University update knowledge of medullary thyroid cancer clinical trial
Published in Pharma Law Weekly, January 23rd, 2007
New research, "Medullary thyroid cancer: therapeutic targets and molecular markers," is the subject of a report. "The present review will provide an update of important studies in medullary thyroid cancer (MTC) with an emphasis on targeted preclinical and translational research studies published over the past 2 years. Recent advances in the biology of MTC, particularly in RET proto-oncogene signaling, are now being translated into promising new therapies and biomarkers," scientists in the United States report.
"Multifunction tyrosine kinase inhibitors that target RET, plus vascular endothelial growth factor receptors and additional kinases, are now being evaluated in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2007-01-23)
More Articles from Pharma Law Weekly
- Asbestosis
Studies conducted at Catholic Medical Center on asbestosis recently published - Bullying
Researchers from Indiana University discuss findings in bullying in children - Business & Finance
IRIDEX now current on its U.S. Securities & Exchange Commission filings - Business Update
Coalition America, Healthx and Bloodhound Technologies plan joint client conference - Business Update
Southern Oncology Association of Practices extends oncology services agreements with OTN, Onmark - Dementia Epidemiology
Researchers at Emory University release new data on dementia epidemiology - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
